Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Cancer Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00898430
What this trial is testing

Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 49
Large-scale testing (Phase 3)Study completedNCT02180867
What this trial is testing

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

Who this might be right for
Alveolar Soft Part SarcomaAngiomatoid Fibrous HistiocytomaAtypical Fibroxanthoma+33 more
National Cancer Institute (NCI) 140
Testing effectiveness (Phase 2)Active Not RecruitingNCT05599360
What this trial is testing

Vyxeos for Induction of Low- or Intermediate-risk.

Who this might be right for
Leukemia, Myeloid, Acute
Shaare Zedek Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT01858922
What this trial is testing

Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A

Who this might be right for
Hodgkin Disease
Baylor College of Medicine 40
Large-scale testing (Phase 3)Study completedNCT00200681
What this trial is testing

IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Nantes University Hospital 493
Testing effectiveness (Phase 2)Study completedNCT00580398
What this trial is testing

Smoking Cessation Intervention for Thoracic Patients

Who this might be right for
Lung Cancer
Massachusetts General Hospital 49
Not applicableEnded earlyNCT03203993
What this trial is testing

China Ovarian Cancer BRCA Testing Study

Who this might be right for
Ovarian Cancer
AstraZeneca 29
Not applicableUnknownNCT06468293
What this trial is testing

Role of Caregiver in the Clinical Pathway of Patients With Breast and Prostate Cancer

Who this might be right for
Cancer
European Institute of Oncology 102
Large-scale testing (Phase 3)Study completedNCT00557193
What this trial is testing

Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Undifferentiated LeukemiaChildhood T Acute Lymphoblastic Leukemia
Children's Oncology Group 218
Testing effectiveness (Phase 2)Study completedNCT00684567
What this trial is testing

Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED)

Who this might be right for
Glioblastoma
Merck Sharp & Dohme LLC 30
Large-scale testing (Phase 3)UnknownNCT02172872
What this trial is testing

"InDACtion" vs "3+7" Induction in AML

Who this might be right for
Acute Myeloid Leukemia (AML)
European Organisation for Research and Treatment of Cancer - EORTC 606
Testing effectiveness (Phase 2)Looking for participantsNCT06982274
What this trial is testing

Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia

Who this might be right for
Acute Promyelocytic Leukemia (APL)
Instituto do Cancer do Estado de São Paulo 115
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07731789
What this trial is testing

Tafasitamab and Rituximab for the Treatment of Newly Diagnosed Follicular Lymphoma

Who this might be right for
Classic Follicular LymphomaGrade 1 Follicular LymphomaGrade 2 Follicular Lymphoma+1 more
University of Washington 30
Testing effectiveness (Phase 2)UnknownNCT00287924
What this trial is testing

High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma

Who this might be right for
Brain and Central Nervous System Tumors
Children's Cancer and Leukaemia Group 29
Testing effectiveness (Phase 2)Study completedNCT00477750
What this trial is testing

Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 33
Not applicableLooking for participantsNCT06202118
What this trial is testing

Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.

Who this might be right for
Breast CancerRecurrent Breast CancerBreast Carcinoma
Alpha Tau Medical LTD. 10
Testing effectiveness (Phase 2)Study completedNCT01062425
What this trial is testing

Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Adult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 261
Testing effectiveness (Phase 2)Study completedNCT00724568
What this trial is testing

Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Michigan Rogel Cancer Center 74
Early research (Phase 1)Study completedNCT00742924
What this trial is testing

Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma

Who this might be right for
Sarcoma
Children's Oncology Group 24
Testing effectiveness (Phase 2)Ended earlyNCT03927222
What this trial is testing

Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma

Who this might be right for
Glioblastoma
Mustafa Khasraw, MBChB, MD, FRCP, FRACP 6
Next Page